A carregar...
Recurrent Pneumonitis in Patients with Melanoma Treated with Immune Checkpoint Inhibitors
INTRODUCTION. Immune checkpoint inhibitors (ICIs) have changed the oncologic landscape in the past few years. Alongside impressive antitumor responses, new novel immune‐related adverse events (irAEs) have emerged; pneumonitis is an irAE that can potentially be fatal and necessitates a proper managem...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6516115/ https://ncbi.nlm.nih.gov/pubmed/30777894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0352 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|